For patients with psoriasis and Type 2 diabetes, the risk of developing chronic kidney disease (CKD) continued to rise ...

The 48-year-old Pekin native and PGA veteran returned to host the 2025 Renewal by Anderson D.A. Points Junior Open, an American Junior Golf Association tour event created with his backing to help ...

Researchers evaluated the efficacy and safety of icotrokinra for treating plaque psoriasis affecting the scalp, genital, and/or hand/foot areas.

Apremilast improved symptom burden and quality of life in patients with genital psoriasis, according to findings published in the Journal of the American Academy of Dermatology. “Genital psoriasis may ...

The primary endpoint was met, with 57% of subjects treated with the therapy achieving clear or almost clear skin at the mark of week 16 based on the IGA score, against the 6% in the placebo group. J&J ...

77% of patients with genital psoriasis achieved a static Physician's Global Assessment of Genitalia (sPGA-G) d score of 0/1 compared to 21% receiving placebo (P<0.001) at 16 weeks.

77% of patients with genital psoriasis achieved a static Physician's Global Assessment of Genitalia (sPGA-G) d score of 0/1 compared to 21% receiving placebo (P<0.001) at 16 weeks.

In the smaller subset of patients with hand/foot psoriasis, patients showed a numerically higher rate of skin clearance at Week 16 with 42% achieving a hand and/or foot Physician's Global Assessment ...

Fact checked by Nick Blackmer Psoriatic arthritis (PsA) is an inflammatory arthritis that causes joint swelling, pain, and stiffness. It's linked to psoriasis, a skin condition causing inflamed, scaly ...

The primary efficacy endpoint in PSOARING 1 (DMVT-505-3001) and PSOARING 2 (DMVT-505-3002) in adults with plaque psoriasis was the proportion of patients who achieved treatment success, defined as a ...